Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall Survival

AIM: The aim of this study was to investigate the association of endocrine complications after ICI immunotherapy with progression-free survival (PFS) and overall survival (OS) in a large single-center oncological cohort. PATIENTS AND METHODS: In total, 351 patients were included in the analysis, 248...

Descripción completa

Detalles Bibliográficos
Autores principales: Paschou, Stavroula A., Liontos, Michael, Eleftherakis-Papaiakovou, Evangelos, Stefanaki, Katerina, Markellos, Christos, Koutsoukos, Konstantinos, Zagouri, Flora, Psaltopoulou, Theodora, Dimopoulos, Meletios-Athanasios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987508/
https://www.ncbi.nlm.nih.gov/pubmed/35402216
http://dx.doi.org/10.3389/fonc.2022.847917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987508/
https://www.ncbi.nlm.nih.gov/pubmed/35402216
http://dx.doi.org/10.3389/fonc.2022.847917

Ejemplares similares